Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Scientists who are trying to understand how to make an HIV vaccine have found the cause of a major roadblock to their work. It turns out that the immune system can indeed produce cells with the potential to manufacture powerful HIV-blocking antibodies; at the same time, though, the immune system works equally hard to make sure these cells are eliminated before they even have a chance to mature. 'Our studies show that a potentially protective neutralizing antibody against a viral disease is under the control of immunological tolerance,' says Barton Haynes, MD, director of the Center for HIV/AIDS Vaccine Immunology at Duke University Medical Center. Haynes is the senior author of the study, which appeared online in the Proceedings of the National Academy of Sciences. 'This represents a new insight into the way HIV effectively evades detection by the B-cell arm of the immune system and may offer new directions for vaccine design.' Over the years scientists have assumed that B cells -- one of the first lines of defense against infection -- are simply not able to 'see' HIV. The virus has the ability to hide its most vulnerable parts from immune system surveillance, and researchers generally assumed that helped explain why B cells often took weeks and even months to arise following infection. But several years ago Duke researchers hypothesized that the antibodies required to broadly neutralize HIV may not be produced in the first place because the immune system sees them as a potential threat -- because of their similarity to antibodies that promote autoimmune disease -- and destroys them. To see if this is indeed what happens, Laurent Verkoczy, Ph.D., an assistant professor of medicine at Duke and the lead author of the study, and Haynes genetically engineered a mouse that could produce only B cells containing a rare but potent broadly neutralizing human antibody that is able to block HIV infection. They found that the mouse's immune system produced plenty of early stage B cells bearing this human neutralizing antibody on their surface but eliminated most of them before they had a chance to fully evolve into mature B cells capable of secreting the antibody. 'This work may mean that we need to think and act very differently in envisioning how a successful vaccine may work,' Verkoczy says. 'The good news is that while about 85% of the 'right' kind of B cells are eliminated, about 15% survive and wind up in circulating blood but are turned off. One goal in vaccine design may be to figure out how to wake them up so that they can go to work.' Adds Haynes: 'We have now unveiled a major reason why members of this class of neutralizing antibodies are not routinely made. Our own immune systems block their production because they are perceived as potentially harmful -- when in reality they are not. This is a very unusual way the virus has developed to evade the immune system.' Haynes says researchers plan on using the new mouse model to test ways to teach the immune system to enable the production of powerful neutralizing antibodies capable of blocking HIV.
From our Sponsors
Most Popular
Why activist Raif Derrazi thinks his HIV diagnosis is a gift
September 17 2024 12:00 PM
How fitness coach Tyriek Taylor reclaims his power from HIV with self-commitment
September 19 2024 12:00 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Out100 Honoree Tony Valenzuela thanks queer and trans communities for support in his HIV journey
September 18 2024 12:00 PM
The freedom of disclosure: David Anzuelo's journey through HIV, art, and advocacy
August 02 2024 12:21 PM
Creator and host Karl Schmid fights HIV stigma with knowledge
September 12 2024 12:03 PM
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM
In honor of Juneteenth 2024, meet The Normal Anomaly
June 19 2024 1:39 PM
Plus: Featured Video
Latest Stories
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
Meet ​our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM
AIDS/LifeCycle is ending after more than 30 years
October 17 2024 12:40 PM
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
October 15 2024 5:03 PM
Kentucky bans conversion therapy for youth as Gov. Andy Beshear signs 'monumental' order
September 18 2024 11:13 AM
Study finds use of puberty blockers safe and reversible, countering anti-trans accusations
September 11 2024 1:11 PM
Latinx health tips / Consejos de salud para latinos (in English & en espanol)
September 10 2024 4:29 PM
The Trevor Project receives $5M grant to support LGBTQ+ youth mental health in rural Midwest (exclusive)
September 03 2024 9:30 AM
Introducing 'Health PLUS Wellness': The Latinx Issue!
August 30 2024 3:06 PM
La ciencia detrás de U=U ha estado liberando a las personas con VIH durante años
August 23 2024 2:48 PM
Tratamiento y prevención del VIH por inyección: Todo lo que necesita saber
August 23 2024 2:41 PM
Sr. Gay World quiere asegurarse de que estés bien
August 23 2024 2:30 PM
Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination
August 20 2024 12:21 PM
With a new case in Sweden, what is the new mpox outbreak and should you be concerned?
August 15 2024 4:48 PM